Micotef (Miconazole)

Miconazole, the active ingredient in Micotef, is an imidazole antifungal presented as a vaginal formulation for local use. It treats vaginal candidiasis by targeting fungal cells and is intended for adult women experiencing yeast infections. GNH USA supplies Micotef as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Micotef belongs to the imidazole antifungal class and is used to treat fungal infections of the female genital tract. - Vaginal candidiasis: eliminates Candida overgrowth and relieves itching, burning and discharge. - Recurrent vulvovaginal candidiasis: reduces the frequency of recurring yeast infection episodes. - Vulvar candidiasis: provides symptomatic relief and eradicates fungal infection of the vulva.

Miconazole may cause local and systemic adverse reactions.

Common Side Effects: - Vaginal irritation or burning sensation. - Itching or mild rash at the application site. - Unpleasant vaginal discharge or odor. - Mild abdominal discomfort.

Serious or Rare Side Effects: - Allergic reaction with swelling, hives or difficulty breathing. - Severe skin reactions such as Stevens‑Johnson syndrome. - Liver toxicity presenting as jaundice or abnormal liver tests.

Use Micotef only after confirming a fungal cause of symptoms and follow prescriber instructions. - Confirm diagnosis: ensure infection is due to Candida before initiating therapy. - Avoid latex condoms: the product may degrade latex and cause irritation. - Allergy check: do not use if known hypersensitivity to imidazoles. - Limit duration: adhere to prescribed treatment length to reduce resistance risk. - Pregnancy and lactation: consult a healthcare professional before use. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Miconazole can interact with other medications, requiring attention to potential effects.

Major Interactions (Avoid): - Systemic azoles (e.g., ketoconazole): may increase systemic absorption of miconazole. - Warfarin: potential enhancement of anticoagulant effect. - Rifampin: may reduce antifungal efficacy.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in effectiveness. - Antacids containing aluminum or magnesium: may affect local absorption. - Topical steroids: may mask local irritation or infection signs.